Supplementary Figure S2 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure S2 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
2. 2Supplementary Figure S3 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
3. 3Supplementary Figure S3 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
4. 4Supplementary Figure S4 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
5. 5Supplementary Figure S4 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024